Hypofractionated radiotherapy to treat acne keloidalis nuchae.

Citation metadata

Date: Oct. 18, 2021
From: CMAJ: Canadian Medical Association Journal(Vol. 193, Issue 41)
Publisher: CMA Impact Inc.
Document Type: Clinical report
Length: 562 words
Lexile Measure: 2310L

Document controls

Main content

Article Preview :

A 27-year-old man of African descent presented to our radiotherapy clinic with a 5-year history of a recurrent 15 * 8 * 4 cm keloidal tumour (i.e., acne keloidalis nuchae) on his posterior neck (Figure 1A). Previous treatments of systemic isotretinoin, antibiotics and surgical excision without adjuvant radiotherapy were unsuccessful, and he was ineligible for re-excision given the size of the lesion. Because he was troubled by the appearance of the lesion, he minimized social contact, which also affected his ability to work.

He underwent definitive radiotherapy using volumetric modulated arc therapy (35 Gy in 5 weekly fractions), with the goal of reducing the keloidal tumour size. After radiotherapy, he required regular wound care during the regression of the lesion. He had no recurrence at 19 months (Figure 1B).

Acne keloidalis nuchae is a chronic inflammatory disorder initiated by hair...

Source Citation

Source Citation   

Gale Document Number: GALE|A678710297